Today's Focus:

Doyen Intl Hold (00668.HK) received a premium of about 78.57% from Silver Union for privatization. It will resume trading tomorrow.

Doyen International Holdings (00668.HK) announced that Silverbond, which holds a 0.785 billion shares (approximately 61.64% of the company's issued share capital) through Hua Yin Shareholders (Hua Yin, Sheng Zhi, Sino Consult, Mr. Luo, and Ms. Zhao (each of them being joint actors of Yin Bond)), proposes to privatize the company with the mortgage interests in the shares.

In view of this, the offeror and the company jointly announced that on August 23, 2024, the offeror requested the board of directors to submit the proposal to the planned shareholders, and privatize the company in accordance with Article 673 of the company's articles of association by way of an agreement arrangement.

According to the plan, the issued planned shares on the record date will be cancelled and removed on the effective date. As a consideration, each planned shareholder will have the right to receive a cash cancellation price of HK$0.350 per canceled and removed planned share, representing a premium of approximately 78.57% over the closing price per share of HK$0.196 on the Hong Kong Stock Exchange on August 23, 2024.

After the plan becomes effective, all issued planned shares on the record date will be canceled and removed, and the stock certificates of such planned shares will no longer have any legal effect. The company will apply to the Stock Exchange for the cancellation of the listing status of the shares on the Stock Exchange in accordance with Rule 6.15(2) of the Listing Rules, which will take effect shortly after the effective date.

Reasons and benefits of implementing the proposal: The proposal provides an opportunity for independent planned shareholders to cash out their shares in a challenging and uncertain market environment. The proposal facilitates the repayment of part of the debt between the offeror and Hua Yin shareholders, while maintaining fair and equal treatment of all planned shareholders. In addition, it reduces the cost and expenses of maintaining the company's listing status and allows the offeror to operate the group's business in a more efficient and effective manner.

As of the date of this announcement, the offeror intends to continue the group's existing business, and the offeror has no immediate plans to make any significant changes to: (a) the group's business (including the reallocation of any fixed assets of the group); or (b) continue to employ employees of the group (except for those involved in day-to-day business operations).

In addition, the company has applied to the Hong Kong Stock Exchange to resume trading of shares from 9:00 am on September 3, 2024.

Important event

BAIC Motor (01958.HK) plans to increase capital by 2 billion yuan to BAIC New Energy.

Unity GP Holdings (01539.HK): Malaysia's energy-saving project has obtained financing of up to 50 million ringgits.

Jinsheng Group (Holdings) (00794.HK): Entered into a relocation compensation agreement with the relocation party and the property owner.

Yuexiu Property (00123.HK): Land Development Center acquires and stores the land on the north side of Sun Yat-sen University.

Operating Data:

Xpeng Motors (09868.HK) delivered a total of 14,036 smart electric vehicles in August, an increase of 26% compared to the previous month.

Medical Innovation:

Shandong Xinhua Pharmaceutical (00719.HK) has obtained approval for the marketing application of esomeprazole magnesium as a chemical raw material drug.

Henlius (02696.HK): The clinical trial application for the biosimilar HLX17 of the monoclonal antibody Pembrolizumab has been approved.

SSY Group (02005.HK): Nicorandil tablets pass consistency evaluation, enhancing the product line for the treatment of angina pectoris.

Simcere Pharma (02096.HK) has signed a cooperation agreement with Tacrigir on the non-small cell lung cancer drug TGRX-326.

Simcere Pharma (02096.HK): Xianbixin sublingual tablets approved as a breakthrough therapy by the US Food and Drug Administration.

Acquisitions and Disposals:

Get Nice (00064.HK) plans to purchase a London city center apartment for 15.046 million British pounds with a lease term of 999 years.

【回购注销】

Stock-Based Incentive:

阿里巴巴-SW(09988.HK)8月30日耗资59.98 million美元回购5.76 million股

Additional Share Issuance:

Detai Newenergy (00559.HK) suggests a capital restructuring, with each trading unit planned to be changed to 0.01 million shares.

gd-hkgba hldgs (01396.HK) plans to conduct a 2-for-1 rights issue, raising a maximum net amount of HKD61.3 million.

Logan International (01355.HK) plans to offer a discount of approximately 18.4% for the sale of up to 89.67 million shares and raise a net amount of 15 million Hong Kong dollars.

石药集团(01093.HK)9月2日耗资49.7107 million港元回购10.5 million股

Repurchase cancellation.

Tencent (00700.HK) spent HKD 1.003 billion on September 2 to repurchase 2.65 million shares.

Alibaba-SW (09988.HK) repurchased 5.76 million shares for a total of $59.98 million on August 30.

hsbc holdings (00005.HK) spent 0.315 billion Hong Kong dollars to repurchase 4.586 million shares on August 30th.

太古股份公司A(00019.HK)9月2日耗资16.12 million港元回购0.2435 million股

Meituan-W (03690.HK) spent HKD 15.2 million to repurchase 0.1313 million shares.

金蝶国际(00268.HK)9月2日耗资10.178 million港元回购1.7 million股

On September 2nd, CSPC Pharma (01093.HK) spent 49.7107 million Hong Kong dollars to repurchase 10.5 million shares.

Guangzhou Automobile Group (02238.HK) repurchased 8.562 million shares on September 2nd at a cost of 19.995 million Hong Kong dollars.

Swire Pacific A (00019.HK) spent 16.12 million Hong Kong dollars on repurchasing 0.2435 million shares on September 2nd.

kingdee int'l (00268.HK) spent 10.178 million Hong Kong dollars to repurchase 1.7 million shares on September 2nd.